Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Atara Biotherapeutics Inc., 3 years.
Chief executive roles
Strong · grade B
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 76
8.5% a year in revenue
20% of the scoring weight is on file. Figures cover December 2023 – December 2025.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
ADC Therapeutics SA June 1, 202699.4%
-
ADC Therapeutics SA June 3, 202599.7%
-
ADC Therapeutics SA June 13, 202499.4%
-
Atara Biotherapeutics Inc. June 10, 202481.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 30, 2026 | ADC Therapeutics SA | Grant or award | +675,000 | — | — |
| Feb 13, 2026 | ADC Therapeutics SA | Grant or award | +900,000 | $3.99 | $3,591,000 |
| Feb 13, 2026 | ADC Therapeutics SA | Shares withheld for tax | −103,231 | $3.99 | $411,892 |
| Dec 6, 2025 | ADC Therapeutics SA | Shares withheld for tax | −233,146 | $3.29 | $767,050 |
| Jun 10, 2025 | Atara Biotherapeutics Inc. | Grant or award | +7,828 | — | — |
| May 6, 2025 | ADC Therapeutics SA | Shares withheld for tax | −26,758 | $1.29 | $34,518 |
| Feb 13, 2025 | ADC Therapeutics SA | Grant or award | +650,000 | $1.61 | $1,046,500 |
| Dec 6, 2024 | ADC Therapeutics SA | Shares withheld for tax | −238,343 | $3.13 | $746,014 |
| May 7, 2024 | ADC Therapeutics SA | Open-market sale | −29,731 | $4.48 | $133,195 |
| Mar 31, 2024 | Atara Biotherapeutics Inc. | Grant or award | +150,000 | — | — |
| May 31, 2023 | Atara Biotherapeutics Inc. | Grant or award | +57,000 | — | — |
Questions about Ameet Mallik
What boards is Ameet Mallik on?
Ameet Mallik sits on the boards of ADC Therapeutics SA and Atara Biotherapeutics Inc.
What company is Ameet Mallik the CEO of?
Ameet Mallik has been Chief Executive Officer of ADC Therapeutics SA since January 2024.
How long has Ameet Mallik served on boards?
Our records show at least 6 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.